Listed

Mesa Laboratories Inc: Form 10-Q for the period ended Dec 31, 2019

Filed with the SEC on Feb 10, 2020 and accepted by EDGAR at Feb 10, 2020, 08:01 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2019-10-01 to 2019-12-31$31.7mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue9 months2019-04-01 to 2019-12-31$83.5mus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2019-10-01 to 2019-12-31$17.0mus-gaap:CostOfRevenue
Cost of revenue9 months2019-04-01 to 2019-12-31$37.2mus-gaap:CostOfRevenue
Gross profit3 months2019-10-01 to 2019-12-31$14.7mus-gaap:GrossProfit
Gross profit9 months2019-04-01 to 2019-12-31$46.3mus-gaap:GrossProfit
Research and development3 months2019-10-01 to 2019-12-31$2.1mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2019-04-01 to 2019-12-31$4.0mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2019-10-01 to 2019-12-31−$3.4mus-gaap:OperatingIncomeLoss
Operating income9 months2019-04-01 to 2019-12-31$6.6mus-gaap:OperatingIncomeLoss
Interest expense3 months2019-10-01 to 2019-12-31$1.9mus-gaap:InterestExpense
Interest expense9 months2019-04-01 to 2019-12-31$3.5mus-gaap:InterestExpense
Income tax3 months2019-10-01 to 2019-12-31−$573.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2019-04-01 to 2019-12-31$792.0kus-gaap:IncomeTaxExpenseBenefit
Net income3 months2019-10-01 to 2019-12-31−$4.6mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2019-04-01 to 2019-12-31$3.0mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2019-10-01 to 2019-12-31−$1.06us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2019-04-01 to 2019-12-31$0.69us-gaap:EarningsPerShareDiluted
Basic EPS3 months2019-10-01 to 2019-12-31−$1.06us-gaap:EarningsPerShareBasic
Basic EPS9 months2019-04-01 to 2019-12-31$0.73us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2019-10-01 to 2019-12-314,367,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2019-04-01 to 2019-12-314,418,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow9 months2019-04-01 to 2019-12-31$18.2mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2019-04-01 to 2019-12-31$935.0kus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Dividends paid9 months2019-04-01 to 2019-12-31$2.0mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2019-12-31$74.0mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2019-12-31$120.7mus-gaap:AssetsCurrent
Total assetsAt period end2019-12-31$423.5mus-gaap:Assets
Current liabilitiesAt period end2019-12-31$25.2mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2019-12-31$189.3mus-gaap:Liabilities
Shareholders' equityAt period end2019-12-31$234.2mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-20-002116. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.